Variables | Overall (N = 232) |
---|---|
Age* | 62 (64–67.8) |
Sex | Â |
Male | 174 (75%) |
Female | 58 (25%) |
BMI* | 22.7 (20.6–24.8) |
Smoking | Â |
Yes | 69 (27.9%) |
No | 163 (70.3%) |
Alcohol | Â |
Yes | 66 (28.4%) |
No | 166 (71.6%) |
Diabetes | Â |
Yes | 34 (14.7%) |
No | 198 (85.3%) |
BCLC stage | Â |
0–A stage | 190 (81.9%) |
B–C stage | 42 (18.1%) |
Child-Pugh | Â |
Grade A | 222 (95.7%) |
Grade B | 10 (4.3%) |
Liver cirrhosis | Â |
Yes | 108 (46.6%) |
No | 124 (53.4%) |
Liver fluke | Â |
Yes | 22 (9.5%) |
No | 210 (90.5%) |
Viral hepatitis B | Â |
Yes | 161 (69.4%) |
No | 71 (30.6%) |
Viral hepatitis C | Â |
Yes | 9 (3.9%) |
No | 223 (96.1%) |
AFP, ng/mL | Â |
≤ 8 | 65 (28%) |
>8 | 167 (72%) |
Tumor number | Â |
Single | 202 (87.1%) |
Multiple | 30 (12.9%) |
Tumor size, cm | Â |
<5 | 132 (56.9%) |
≥ 5 | 100 (43.1%) |
Venous tumor emboli | Â |
Yes | 28 (12.1%) |
No | 204 (87.9%) |
Time of operation* | 240 (172–296) |
Bleeding* | 350 (200–600) |
Local chemotherapy | Â |
Yes | 73 (31.5%) |
No | 159 (68.5%) |
Radical resection | Â |
Yes | 139 (59.5%) |
No | 94 (40.5%) |
Laparoscopic hepatectomy | Â |
Yes | 54 (23.3%) |
No | 178 (76.7%) |
Differentiated degree | Â |
High | 14 (6%) |
Middle | 205 (88.4%) |
Low | 13 (5.6%) |
Microvascular invasion | Â |
Yes | 64 (27.6%) |
No | 168 (72.4%) |
Length of stay* | 18 (14–22) |
Clavien–Dindo |  |
I and II | 226 (97.4%) |
III, IV and V | 6 (2.6%) |
Overall survival* | 37 (23.4–57.6) |
Survival status | Â |
Alive | 184 (79.3%) |
Death | 48 (20.7%) |
Recurrence | Â |
Yes | 69 (29.7%) |
No | 163 (70.3%) |
TTS* | 18 (14–29.8) |